New structures of the glucagon-like peptide-1 (GLP-1) and glucagon receptors in complex with peptide and nonpeptide ligands provide a comprehensive, detailed picture of the molecular mechanisms of action of family B GPCRs. This opens the door for true structure-based drug discovery aimed at both novel orthosteric and allosteric subsites of the receptors.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Zhang, Y. et al. Nature 546, 248–253 (2017).
Jazayeri, A. et al. Nature 546, 254–258 (2017).
Song, G. et al. Nature 546, 312–315 (2017).
Zhang, H. et al. Nature 546, 259–264 (2017).
Hjorth, S.A. & Schwartz, T.W. Acta Physiol. Scand. 157, 343–345 (1996).
Liang, Y.L. et al. Nature 546, 118–123 (2017).
Rasmussen, S.G. et al. Nature 477, 549–555 (2011).
Sparre-Ulrich, A.H. et al. Biochem. Pharmacol. 131, 78–88 (2017).
Jazayeri, A. et al. Nature 533, 274–277 (2016).
Nolte, W.M. et al. Nat. Chem. Biol. 10, 629–631 (2014).
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Schwartz, T., Frimurer, T. Full monty of family B GPCRs. Nat Chem Biol 13, 819–821 (2017). https://doi.org/10.1038/nchembio.2438
Published:
Issue Date:
DOI: https://doi.org/10.1038/nchembio.2438